Working group on hepatotoxicity studiesLUCENA, M. I.Methods and findings in experimental and clinical pharmacology. 1999, Vol 21, pp 43-44, issn 0379-0355, SUPBConference Paper

Aminoglycoside-associated nephrotoxicity in extrahepatic obstructive jaundiceLUCENA, M. I; ANDRADE, R. J; CABELLO, M. R et al.Journal of hepatology. 1995, Vol 22, Num 2, pp 189-196, issn 0168-8278Article

Serum protein binding of tolbutamide in patients treated with antiepileptic drugsFERNANDEZ, M. C; ERILL, S; LUCENA, M. I et al.Clinical pharmacokinetics. 1985, Vol 10, Num 5, pp 451-455, issn 0312-5963Article

Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis: Results of a randomized, double-blind, placebo-controlled clinical studyLUCENA, M. I; ANDRADE, R. J; DE LA CRUZ, J. P et al.International journal of clinical pharmacology and therapeutics. 2002, Vol 40, Num 1, pp 2-8, issn 0946-1965Article

Chronic liver injury related to use of bentazepam : An unusual instance of benzodiazepine hepatotoxicityANDRADE, R. J; LUCENA, M. I; AGUILAR, J et al.Digestive diseases and sciences. 2000, Vol 45, Num 7, pp 1400-1404, issn 0163-2116Article

Haemodynamic and endocrine effects of digitoxin in healthy volunteersLUCENA, M. I; MORENO, A; DEL RIO C., G et al.International journal of clinical pharmacology research. 1987, Vol 7, Num 2, pp 135-140, issn 0251-1649Article

Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitisLUCENA, M. I; KAPLOWITZ, N; HALLAL, H et al.Journal of hepatology. 2011, Vol 55, Num 4, pp 820-827, issn 0168-8278, 8 p.Article

Trovafloxacin-induced acute hepatitisLUCENA, M. I; ANDRADE, R. J; RODRIGO, L et al.Clinical infectious diseases. 2000, Vol 30, Num 2, pp 400-401, issn 1058-4838Article

Enhance gentamicin nephrotoxicity after experimental biliary obstruction in ratsLUCENA, M. I; GONZALEZ-CORREA, J. A; ANDRADE, R. J et al.Pharmacology & toxicology. 1989, Vol 65, Num 5, pp 352-356, issn 0901-9928, 5 p.Article

Digitoxin elemination in healthy subjects taking apicillinLUCENA, M. I; MORENO, A; FERNANDEZ, M. C et al.International journal of clinical pharmacology research. 1987, Vol 7, Num 1, pp 33-37, issn 0251-1649Article

Evaluation of Naranjo Adverse Drug Reactions Probability Scale in causality assessment of drug-induced liver injuryGARCIA-CORTES, M; LUCENA, M. I; PACHKORIA, K et al.Alimentary pharmacology & therapeutics. 2008, Vol 27, Num 9, pp 780-789, issn 0269-2813, 10 p.Article

Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI)PACHKORIA, K; LUCENA, M. I; RUIZ-CABELLO, F et al.British journal of pharmacology. 2007, Vol 150, Num 6, pp 808-815, issn 0007-1188, 8 p.Article

Fulminant liver failure associated with flutamide therapy for hirsutismANDRADE, R. J; LUCENA, M. I; FERNANDEZ, M. C et al.Lancet (British edition). 1999, Vol 353, Num 9157, issn 0140-6736, p. 983Article

Short-term effect of various doses of cyclosporin A on plasma lipoproteins and its distribution in blood : an experimental studyANDRADE, R. J; LUCENA, M. I; GONZALEZ-CORREA, J. A et al.Human & experimental toxicology. 1993, Vol 12, Num 2, pp 141-146, issn 0960-3271Article

Effect of experimental bile duct ligation on distribution of cyclosporin A among plasma lipoproteinsANDRADE, R. J; LUCENA, M. I; GONZALEZ-CORREA, J. A et al.Transplantation proceedings. 1993, Vol 25, Num 5, pp 2973-2977, issn 0041-1345Conference Paper

Bronchodilator effect and serum theophylline level after combined treatment with fenoterol and theophylline in reversible chronic airflow obstructionLUCENA, M. I; ALMAGRO, J; RIUS, F et al.European journal of clinical pharmacology. 1988, Vol 35, Num 6, pp 669-671, issn 0031-6970Article